Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 10 search results for "Clinical trials" in Resources. To see all results and access other features, sign up for free.

... Dystrophy AssociationEstimation of Clinical Trial Success Rates and Related Parameters — BiostatisticsLearning About Clinical Trials — Cure SMAPublic Workshop: Evaluating Inclusion and Exclusion Criteria in Clinical Trials (Workshop Report) — U.S. ...
How Do Clinical Trials Work for SMA?
... Dystrophy AssociationEstimation of Clinical Trial Success Rates and Related Parameters — BiostatisticsLearning About Clinical Trials — Cure SMAPublic Workshop: Evaluating Inclusion and Exclusion Criteria in Clinical Trials (Workshop Report) — U.S. ...
... — BMJClinical Trials — University of Rochester Medical Center ...
Are Clinical Trials Safe for People With SMA?
... — BMJClinical Trials — University of Rochester Medical Center ...
... Clinical Trials Help Others by Advancing ResearchPeople with SMA participate in clinical trials for a variety of reasons, not least of which is to contribute to research that can potentially help others. ...
5 Reasons To Consider Participating in SMA Clinical Trials
... Clinical Trials Help Others by Advancing ResearchPeople with SMA participate in clinical trials for a variety of reasons, not least of which is to contribute to research that can potentially help others. ...
... Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) — Scholar Rock Phase 3 Active Treatment Trial To Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam (SAPPHIRE) — ClinicalTrials.gov ...
Posted 12/22/2021
Participants Sought for Clinical Trial of SMA Muscle Therapy Apitegromab
... Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA) — Scholar Rock Phase 3 Active Treatment Trial To Evaluate the Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Who Are Being Treated With Nusinersen or Risdiplam (SAPPHIRE) — ClinicalTrials.gov ...
Posted 12/22/2021
... Disorders Spinal Muscular Atrophy — National Institute of Neurological Disorders and Stroke A Modified Hammersmith Functional Motor Scale for Use in Multi-Center Research on Spinal Muscular Atrophy — Neuromuscular Disorders Hammersmith Functional Motor Scale – Expanded (HFMSE) — Biogen Revised Hammersmith Scale for Spinal Muscular Atrophy: A SMA Specific Clinical ...
What Is the Hammersmith Functional Motor Scale for SMA?
... Disorders Spinal Muscular Atrophy — National Institute of Neurological Disorders and Stroke A Modified Hammersmith Functional Motor Scale for Use in Multi-Center Research on Spinal Muscular Atrophy — Neuromuscular Disorders Hammersmith Functional Motor Scale – Expanded (HFMSE) — Biogen Revised Hammersmith Scale for Spinal Muscular Atrophy: A SMA Specific Clinical ...
... References Biohaven Commences Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy — NeurologyLive Spinal Muscular Atrophy — MedlinePlus NeuroVoices: Lindsay Lee Lair, MD, on the Phase 3 RESILIENT Trial of Taldefgropeb Alfa in SMA — NeurologyLive NIH Clinical Research Trials and You — National Institutes of Health A Study to Evaluate the Efficacy ...
Posted 08/17/2022
Study Recruiting for New Add-On SMA Treatment
... References Biohaven Commences Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy — NeurologyLive Spinal Muscular Atrophy — MedlinePlus NeuroVoices: Lindsay Lee Lair, MD, on the Phase 3 RESILIENT Trial of Taldefgropeb Alfa in SMA — NeurologyLive NIH Clinical Research Trials and You — National Institutes of Health A Study to Evaluate the Efficacy ...
Posted 08/17/2022
... His research expertise is developing outcome measurement tools for pharmaceutical trials. Dr. Heatwole focuses on SMA, as well as other neuromuscular conditions. Dr. Heatwole was also involved in validating the SMA-HI. ...
Posted 09/15/2021
Caregivers Sought for SMA Outcome Tool Validation Study
... His research expertise is developing outcome measurement tools for pharmaceutical trials. Dr. Heatwole focuses on SMA, as well as other neuromuscular conditions. Dr. Heatwole was also involved in validating the SMA-HI. ...
Posted 09/15/2021
... References Spinal Muscular Atrophy (SMA) — Cleveland Clinic Motor Skills — ScienceDirect Spinal Muscular Atrophy: The Use of Functional Motor Scales in the Era of Disease-Modifying Treatment — Child Neurology Open See Baby’s Milestones — Pathways.org Appendix 5: Validity of Outcome Measures — Clinical Review Report: Nusinersen (Spinraza): (Biogen ...
What Is the HINE-2 Motor Test for SMA?
... References Spinal Muscular Atrophy (SMA) — Cleveland Clinic Motor Skills — ScienceDirect Spinal Muscular Atrophy: The Use of Functional Motor Scales in the Era of Disease-Modifying Treatment — Child Neurology Open See Baby’s Milestones — Pathways.org Appendix 5: Validity of Outcome Measures — Clinical Review Report: Nusinersen (Spinraza): (Biogen ...
... Clinical trials are underway to explore possible new therapies and discover new uses for existing treatments. Researchers are still learning more about SMA and making treatment advances. ...
Posted 11/16/2022
New Study: Zolgensma May Benefit Adults With SMA Types 2 and 3
... Clinical trials are underway to explore possible new therapies and discover new uses for existing treatments. Researchers are still learning more about SMA and making treatment advances. ...
Posted 11/16/2022
... For most children in Zolgensma clinical trials, liver enzyme levels returned to normal within two months. However, high enzyme levels can sometimes progress to worse liver problems. Out of 43 children treated with Zolgensma outside of clinical trials, two developed liver injury, which was successfully treated. ...
Posted 11/30/2021
SMA Medication Zolgensma May Cause Liver Failure, Warns New Label Update
... For most children in Zolgensma clinical trials, liver enzyme levels returned to normal within two months. However, high enzyme levels can sometimes progress to worse liver problems. Out of 43 children treated with Zolgensma outside of clinical trials, two developed liver injury, which was successfully treated. ...
Posted 11/30/2021